mRNA |
AZD6244 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.009 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.009 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.009 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
TL-1-85 |
GDSC1000 |
pan-cancer |
AAC |
0.082 |
0.01 |
mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.01 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |